cancer

Eli Lilly, Merck, Pfizer starting not-for-profit cancer research center in Asia
Yahoo/AP
Tue, 02/23/10 - 10:45 am
cancer
Eli Lilly
Merck
Pfizer
Asia
partnerships
FDA Boasts About Approvals Of Cancer Drugs
Pharmalot
Fri, 02/19/10 - 10:45 am
FDA
cancer
CytRx Puts Its Cancer Pipeline to the Test
Seeking Alpha
Fri, 02/19/10 - 09:27 am
CytRx
cancer
pipelines
For Blockbuster Cancer Drugs, Approvals Are the Easy Part
Motley Fool
Tue, 02/16/10 - 03:27 pm
cancer
Pfizer
Sanofi
JNJ
Doxil
Gleevac
Novartis
Lyrica
Erbitux
3SBio, Ascentage Form Alliance to Develop Cancer Drugs
Seeking Alpha
Tue, 02/16/10 - 09:37 am
cancer
partnerships
Ascentage
3SBio
China
Curis lands $8M as cancer-drug trial advances
bizjournals.com
Sat, 02/13/10 - 10:48 am
Curis
Debiopharm
cancer
Cel-Sci Cancer Drug Claims Crumble (Part 2)
TheStreet.com
Thu, 02/11/10 - 08:42 am
Cel-Sci
Multikine
cancer
Cel-Sci Cancer Drug Claims Crumble (Part 1)
TheStreet.com
Thu, 02/11/10 - 08:40 am
Cel-Sci
cancer
Multikine
Eventful Year Expected for Access Pharma
Seeking Alpha
Mon, 02/8/10 - 09:41 am
Access Pharmaceuticals
cancer
Keryx Biopharmaceuticals, AEterna Zentaris report positive perifosine study data
Yahoo/AP
Fri, 01/29/10 - 11:01 am
perifosine
Keryx
Aeterna Zentaris
cancer
Teva Moves Ahead in Brain Drug Battle
Forbes
Tue, 01/26/10 - 05:55 pm
Teva Pharmaceuticals
Merck
Temodar
cancer
Keryx and AEterna Zentaris say perifosine improved survival compared to potential competitor
Yahoo/AP
Mon, 01/25/10 - 03:57 pm
Aeterna Zentaris
Keryx
cancer
perifosine
Geron reports anticancer activity in preclinical study on developing drug imetelstat
Yahoo/AP
Tue, 01/5/10 - 12:13 pm
Geron
cancer
imetelstat
Dynavax wraps up Symphony Dynamo deal
Bizjournals.com
Mon, 01/4/10 - 02:17 pm
Dynavax
Symphony Dynamo
cancer
Good News for Vical Candidate
Yahoo/Zacks.com
Wed, 12/30/09 - 05:18 pm
Vical
FDA
cancer
Allovectin-7
Cell Therapeutics adopts 'poison pill' plan
Yahoo/AP
Mon, 12/28/09 - 10:13 am
poison pill
Cell Therapeutics
FDA
cancer
pixantrone
FDA Says 'Unlikely' That Vytorin, Zetia Increase Cancer Risk
WSJ Online
Tue, 12/22/09 - 04:09 pm
Vytorin
Zetia
cancer
FDA
Celgene's Revlimid meets cancer study goal
Yahoo/AP
Fri, 12/18/09 - 10:43 am
Revlimid
cancer
Celgene
clinical trials
Multiple Myeloma
Millennium strikes $365M deal for Seattle Genetics' cancer antibody
Fierce Biotech
Tue, 12/15/09 - 09:25 am
Seattle Genetics
Millennium
antibodies
cancer
Merck Starts China Trial of Cancer Vaccine
Seeking Alpha
Mon, 12/14/09 - 07:35 am
cancer
Merck
China
vaccines
Stimuvax

Pages